EUDA Health Holdings (EUDAW) furnishes Form 6-K press release report

Rhea-AI Filing Summary

EUDA Health Holdings Limited, a foreign private issuer based in Singapore, submitted a Form 6-K for September 2025. The company reports an “Other Events” item and furnished a press release dated September 10, 2025, as Exhibit 99.1.

The report is signed by Interim Chief Financial Officer Vivian Tay on behalf of the company.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

Commission File Number: 001-40678

EUDA Health Holdings Limited

(Exact Name of Registrant as Specified in its Charter)

60 Kaki Bukit Place, #03-01

Eunos Techpark, Singapore 415979.

(Address of Principal Executive Offices and Zip Code)

Registrant’s telephone number, including area code: +65 6327 1110.

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Other Events.

On September 10, 2025, EUDA Health Holdings Limited issued the press release filed herewith as Exhibit 99.1.

Exhibits

99.1 Press release dated September 10, 2025.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Dated: September 10, 2025
	EUDA Health Holdings Limited
	By:	/s/ Vivian Tay
	Name:	Vivian Tay
	Title:	Interim Chief Financial Officer

FAQ

What does EUDAW EUDA Health Holdings disclose in this Form 6-K?

EUDA Health Holdings Limited filed a Form 6-K reporting an “Other Events” item. It furnished a press release dated September 10, 2025, as Exhibit 99.1, making that document part of its official U.S. securities disclosure record.

When did EUDAW EUDA Health issue the press release referenced in the Form 6-K?

The press release referenced in the Form 6-K was issued on September 10, 2025. That same date appears on the signature block, aligning the timing of the release with the company’s submission of this foreign private issuer report.

Who signed the September 2025 Form 6-K for EUDAW EUDA Health?

The Form 6-K was signed on behalf of EUDA Health Holdings Limited by Vivian Tay. She is identified in the document as the Interim Chief Financial Officer, acting as the duly authorized representative for this submission.

What type of event does the EUDAW EUDA Health Form 6-K describe?

The Form 6-K describes an “Other Events” item, a category used for material information that does not fit specific predefined items. In this case, the company uses it to furnish a related press release as Exhibit 99.1.

What exhibit is attached to the EUDAW EUDA Health September 2025 Form 6-K?

The Form 6-K includes a single referenced exhibit, labeled Exhibit 99.1. This exhibit consists of the press release issued by EUDA Health Holdings Limited on September 10, 2025, and is incorporated into the company’s U.S. disclosure.